Rockefeller Capital Management
IDYA icon

Rockefeller Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Rockefeller Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Sell
431
-101
-19% -$3.09K ﹤0.01% 3818
2026
Q1 		$17.7K Sell
532
-3,263
-86% -$109K ﹤0.01% 3755
2025
Q4 		$131K Buy
3,795
+3,471
+1,071% +$111K ﹤0.01% 2580
2025
Q3 		$8.82K Buy
+324
New +$7.84K ﹤0.01% 3699

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Rockefeller Capital Management's IDYA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its IDEAYA Biosciences (IDYA) stake by 19% in Q2 2026, selling an estimated $3.09K and leaving 431 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.

Rockefeller Capital Management first reported a position in IDYA in Q3 2025 and has held it in 4 quarters since. The position peaked at $131K in Q4 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Rockefeller Capital Management held 431 shares of IDEAYA Biosciences worth $16.1K as of Q2 2026.
  • Rockefeller Capital Management sold 101 IDEAYA Biosciences shares in Q2 2026, an estimated $3.09K.
  • IDEAYA Biosciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3818 holding.
  • Rockefeller Capital Management first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's IDEAYA Biosciences position peaked at $131K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.